Abstract
INTRODUCTION
Mycoplasmas are characterized by their small size and lack of cell wall and several species are pathogenic in humans. Following its isolation from the male urethra in 1980, M. genitalium infection was linked to several reproductive tract syndromes in men and women including urethritis, cervicitis, and possibly pelvic inflammatory disease (PID), as well as infertility, and pre-term delivery [1] . Globally, in low-risk female populations (those not attending STI or fertility clinics) the average prevalence is approximately 2.0%, similar to the overall prevalence of Chlamydia trachomatis in women in the United States (2.5%) [2, 3] . In high-risk women, the average prevalence of M. genitalium infection is substantially higher (7.3%), but ranges from 0% to 42%, depending on the setting [2] . Although the association between M. genitalium infection and nongonococcal urethritis (NGU) in men is well established, the association with female reproductive tract disease is less clear [1] .
Annually, in the United States, sexually transmitted infections (STIs) result in over $16 billion in direct healthcare costs, with the highest burden borne by younger individuals [3, 4] . In most women, sexually transmitted pathogens first establish infection in the vagina or cervix, paving the way for ascension to the upper reproductive tract and risk for PID. Although no recent cost data are available, estimates from 1990 suggested that the direct and indirect cost of PID and PID-associated ectopic pregnancy and infertility was $4.2 billion and would reach $10 billion by 2000 [5] . Given these costs, screening and treatment programs have been developed for Chlamydia trachomatis and Neisseria gonorrhoeae; organisms clearly linked to PID.
Mycoplasma genitalium is a recently emerging STI, and there are no estimates of the direct and indirect cost due to infection and sequelae. However, even if only a portion of PID is caused by M. genitalium, infection with this organism would result in substantial direct and indirect cost globally.
Meta-analysis is a commonly used technique to pool information from several studies to provide a summary estimate of the association of interest. It is a particularly useful tool for combining studies with small populations, similar study designs and outcomes, and studies with lower power. Meta-analysis also provides a systematic approach to summarizing available literature that includes standardized criteria for identifying and selecting information from studies that prevents selective inclusion and subjective weighting of studies.
A systematic review and meta-analysis, assessing the association between M. genitalium infection and NGU in men and cervicitis in women was published in 2011 [1] . This review evaluated studies published from 1997-2009, but did not generate pooled estimates for female upper reproductive tract infections (infections of the uterus, ovaries, or fallopian tubes such as PID, infertility, and adverse pregnancy outcomes) [1] . Another review, published in 2011, summarized the literature studying the association between M. genitalium infection and female reproductive tract infections, but a formal meta-analysis was not conducted [2] . Since the publication of these reviews, several recent studies on the possible association between M. genitalium and female reproductive tract infections have been published, making an up-to-date meta-analysis of this information merited.
We conducted a meta-analysis of studies published between 1980 and the present on the association between M. genitalium infection and female reproductive tract disease, namely cervicitis, female infertility, adverse pregnancy outcomes, and PID. Since the pathogenesis of these conditions is sufficiently different, we assessed each of them separately. We also assessed to what extent heterogeneity was present among the studies included in these analyses and to what extent publication bias may have impacted our conclusions. Where the number of studies allowed, we assessed whether the association between M. genitalium infection and these female reproductive tract disease outcomes varied by geographic region or method of detection (nucleic acid amplification test (NAAT) vs. serology) of M. genitalium, through stratified analysis.
METHODS
To assess the relationship between M. genitalium infection and female reproductive tract disease, we conducted one meta-analysis for each of the female reproductive tract disease syndromes for a total of four meta-analyses. The primary exposure was detection of M.
genitalium determined through nucleic acid amplification test (NAAT), serology, or culture. The four outcomes of interest were cervicitis, adverse pregnancy outcomes, female infertility, and pelvic inflammatory disease (PID). Inclusion and Exclusion Criteria: Studies were included if they met the following criteria: 1) The authors reported data from an original peer-reviewed study, 2) the study employed a crosssectional, cohort, or case-control design, 3) the study provided adequate description of the assay used to detect M. genitalium and sufficient data to determine the association between M. genitalium and reproductive tract syndromes, and 4) the study was published in English. Many of these outcomes are clinically defined or not standardly defined; therefore published articles used varying definitions for their outcomes. All definitions of the outcome were included in the search criteria and articles were selected for inclusion if they had defined their exposure and outcome measurement with sufficient detail to evaluate comparability with other studies. Studies were excluded if they reported only on the development of laboratory assays, or were studies of genomics, case series or animal studies, had no comparison group, or reported only on prevalence. Articles were also excluded if they reported on clinical guidelines or were conference abstracts or editorials/letters. If there were overlapping studies from the same population, the study with the most complete population size and analysis was chosen for inclusion. Databases were queried several times throughout the meta-analysis study to ensure complete coverage of current literature. Data Abstraction and Review: All relevant data were extracted simultaneously by two reviewers (RL and LEM) using a standardized data collection form. Discrepancies were discussed between the two reviewers and a consensus on inclusion and data elements was reached. Data were collected for the following items: first author, year, study location, study design, study population, sample size, method used to detect M. genitalium, definition of the outcome, crude effect estimate, and adjusted effect estimate (if available, including covariates). If crude effect estimates were not presented in the study, estimates were calculated by the investigation team and provided in summary tables. If crude effect estimates could not be calculated from the available data, authors were contacted to provide additional information. If estimates were provided for multiple definitions of the outcome, objective definitions (e.g. PMN counts, laparoscopy) were used over subjective definitions (clinical diagnosis). If multiple objective definitions of the outcome were presented, estimates that used the most rigorous definition (e.g. highest PMN counts) were included in the analysis.
Quality Assessment: While the Cochrane Collaboration tool for assessing the quality and bias is widely used for randomized control trials [6] , no standard tool exists for evaluating the quality of observational studies. However, several criteria have been outlined as important areas to consider for potential bias in observational studies [7] . Based on these criteria, we assessed the source population, selection of participants, strength of the exposure measurement, strength of the outcome measure, control for confounding, if the association of interest was a primary or secondary analysis, and other potential biases (e.g., possible conflicts of interest) of each study.
Because of reported concerns about quality assessment scales that assign a numerical score [7] , we chose to provide studies with an overall score of poor, fair or good based on the defined criteria areas. Due to the lack of a standardized rating mechanism, we assigned the ratings based on expert knowledge of the topic area and study techniques. Studies were designated as good if no more than two of the above criteria were assigned a fair rating, as fair if three or more of the criteria were assigned a fair rating, and as poor if two or more of the criteria were assigned a poor rating (Appendix B for full rating scheme).
Data Analysis: Data were aggregated across studies for each syndrome to determine an overall summary estimate using random effects models. This approach assumes that the studies in the analysis are a sample of a larger population of studies and incorporates an estimate of betweenstudy variance as well as within-study variance, producing a more conservative estimate. Studies in which findings had a zero cell were included in the meta-analysis by assigning a 0.5 as the cell count in order to provide an effect estimate and 95% confidence interval (CI). All models were executed first using crude estimates only and subsequently using the adjusted estimate for studies that provided them. All data presented are from the model incorporating the adjusted estimate where available and crude estimates for studies that did not provide an adjusted estimate.
Heterogeneity between studies was assessed using the I 2 statistic, which does not depend greatly on the number of studies in the analyses. I 2 indicates the proportion of the total variation in the estimates that is due to variation between studies rather than to chance; values less than 30 percent were considered minimal heterogeneity and values greater than 50 percent were deemed considerable heterogeneity [8] . If there was substantial heterogeneity, a sensitivity analysis was conducted for each of the subgroups by method of exposure measurement (NAATs and serology) to determine if this significantly changed the association with the outcomes.
Funnel plots were used to provide a visual assessment of the presence of possible publication bias. To aid in the interpretation of the funnel plots, we performed the Begg adjusted rank correlation test, a numerical analogue to the funnel plot [9] . To account for the potentially lower power of the Begg test, we also performed the Egger et al. regression asymmetry test [10] .
All data analyses were conducted using STATA 13.1. These analyses of published literature did not require Institutional Review Board approval.
RESULTS
Overall, the systematic search for studies of M. genitalium and female reproductive tract disease syndromes returned a total of 822 titles, 266 of which evaluated cervicitis, 177 assessed infertility, 117 were on pregnancy outcomes, and 262 studied PID. Each systematic review and meta-analysis is described separately below.
M. genitalium and Cervicitis
After exclusion of duplicate citations from the databases, 158 potentially eligible references to studies reporting on M. genitalium and cervicitis were identified (Fig. 1 ). Of these, 137 were excluded based on a review of the titles, abstracts, and publication language. Three additional studies were excluded following full-text review; one did not provide data on the association between M. genitalium and cervicitis [11] , one evaluated an outcome other than cervicitis [12] , and one did not provide sufficient data to determine the association between M. genitalium and cervicitis [13] .
A total of nineteen studies were included in the meta-analysis of the association between cervicitis and M. genitalium and a summary of the included studies can be found in Table 1 . Of the studies included for the cervicitis analysis, nine were designated as good [14] [15] [16] [17] [18] [19] [20] [21] [22] and ten were designated as fair [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] in terms of methodologic quality (Appendix C). Adjusted effect estimates were provided in nine studies [14, 16, 18, 19, 21, 22, 27, 31, 32] . Seven studies reported crude effect estimates in the original text [17-20, 22, 25, 32] , and 11 studies reported data that allowed us to calculate crude effect estimates [14, 15, 21, 23, 24, [26] [27] [28] [29] [30] [31] . Authors were contacted for more information for two of the studies [16, 19] and one provided additional information to calculate a crude effect estimate [19] . Sixteen studies used polymerase chain reaction (PCR) [14-17, 19-28, 30, 31] , two studies employed the transcription-mediated amplification (TMA) assay [29, 32] and one study used both TMA and PCR to detect M.
genitalium [18] . Eight studies employed a microbiological definition of cervicitis [15-17, 19, 21, 25, 26, 28] , six studies employed a clinical definition of cervicitis [18, 20, 22, 27, 29, 32] , and five studies used a combination of microbiologic and clinical definitions [14, 23, 24, 30, 31] .
Three of the studies used a case-control study design [24, 27, 31] while the remaining sixteen used a cross-sectional study design [14-23, 25, 26, 28-30, 32] .
In 
M. genitalium and Female Infertility
After exclusion of duplicate citations from the databases 102 potentially eligibly references were identified (Fig. 3 ). Ninety-four references were excluded based on title and abstract review. Three studies were excluded following full text review; one study had no comparison group [33] , one study did not detect any M. genitalium in the patients [34] , and one study detected M. genitalium in only one patient [35] .
A total of five studies were included in the meta-analysis of the association of M.
genitalium and female infertility and are summarized in Table 2 . Of the studies included in the female infertility analysis, three were designated as good [36] [37] [38] and two were designated as fair [39, 40] in terms of methodologic quality (Appendix C). Adjusted effect estimates were reported in three studies [36] [37] [38] , two studies reported a crude effect estimate [36, 37] and crude effect estimates were calculated from available data for three studies [38] [39] [40] . Four studies evaluated women attending fertility clinics, comparing confirmed tubal factor infertility (TFI) to other causes of infertility through laparoscopy, culdoscopy or hysterosalpingography (HSG) [36, 37, 39, 40] . One study evaluated women with clinically diagnosed PID and infertility was defined as sexually active women who were not pregnant after 12 months of follow-up despite rare or no use of contraceptives [38] . Two of the studies had relatively small sample sizes (n=74 [40] and n=106 [39] ), two had moderate sized samples (n=194 [37] and n=241 [36] ) and one had a fairly large sample (n=586 [38] ). Three of the studies detected M. genitalium infection using serology [36, 37, 39] and two of the studies used PCR [38, 40] . Four of the studies used a case-control study design [36, 37, 39, 40] and one employed a cross-sectional design [38] .
In the meta-analysis of all five included studies, the pooled OR was 2.43 (95% CI: 0.93, 6.34), although this was not statistically significant (Fig 4) . There was high between-study heterogeneity (I 2 =80.2% (95% CI: 53.5%, 91.6%)), but no significant publication bias (Begg pvalue=0.62, Egger p-value=0.70). The earliest study had notably different findings using a first generation serology assay and was identified as a possible outlier [39] . In a sub-analysis excluding this study, the association between M. genitalium and female infertility was stronger and statistically significant (pooled OR 3.46 (95% CI: 1.51, 7.93)). Exclusion of this potential outlier also reduced the level of heterogeneity to modest (I 2 =64.4% (95% CI: 0.0%, 87.6%)).
M. genitalium and Pregnancy Outcomes
After exclusion of duplicate citations from the databases, 85 potentially eligibly references were identified (Fig. 5 ). Seventy-three references were excluded based on review of title, abstract, or publication language. Three studies were excluded following full text review;
one study did not provide data on the association between M. genitalium and pregnancy outcomes [41] , one study did not have a comparison group [42] , and one study did not detect M.
genitalium in the participants [43] .
A total of nine studies met the inclusion criteria for pregnancy outcomes (Table 3 ), but only eight were included in the quantitative meta-analysis. Seven of these studies were designated as good [44] [45] [46] [47] [48] [49] [50] and two were designated as fair [14, 51] in terms of methodologic quality (Appendix C). One study assessed ectopic pregnancy and was evaluated separately [47] .
All eight studies included in the meta-analysis presented information on preterm birth or spontaneous abortion. Two of the studies presented additional information on the association of M. genitalium and stillbirth [44, 50] . All of the outcomes were defined clinically. Adjusted effect estimates were reported in three studies [48] [49] [50] , five studies reported a crude effect estimate [44, [48] [49] [50] [51] and crude effect estimates were calculated from available data for three studies [14, 45, 46] . Seven of the studies assessed M. genitalium using PCR [14, [44] [45] [46] [49] [50] [51] while only one study used TMA [48] . Three of the studies used a case-control study design [44, 48, 49] , three used a cohort design [45, 46, 51] , and two used a cross-sectional design [14, 50] .
In the primary meta-analysis of the eight included studies, we evaluated a combined outcome of either preterm birth or spontaneous abortion, assuming each constituted some form of premature expulsion of the fetus. There was a statistically significant association between M.
genitalium and the combined outcome of preterm birth and spontaneous abortion with a pooled 
M. genitalium and PID
After exclusion of duplicate citations from the databases 167 potentially eligibly references were identified (Fig. 7) . One hundred fifty references were excluded based on a review of title, abstract, and publication language. A further seven studies were excluded following full-text review; two studies did not have a comparison group [33, 52] , one study had the same population as another more complete study [53] , one study did not have an uninfected comparison group [54] , one study did not have a clinically defined outcome (i.e. history of PID) [49] , one study did not have a comparison group without PID [55] , and one study was a reprint of another included study [56] .
A total of ten studies were included in the meta-analysis of the association between M.
genitalium and PID and are summarized in Table 4 . Of the studies included in the PID analysis, five were designated as good [20, 38, 47, 57, 58] and five were designated as fair [31, [59] [60] [61] [62] in terms of methodologic quality (Appendix C). Adjusted effect estimates were presented in the text for four studies [31, 38, 47, 58] , four presented a crude estimate [20, 38, 47, 62] , and crude effect estimates were calculated from available data for six studies [31, [57] [58] [59] [60] [61] . Seven studies assessed M. genitalium using PCR [31, 38, 57, 58, 60, 62] , two studies used serology [47, 59] , and one study used PCR and serology [61] . Two studies microbiologically defined their outcome as endometritis [38, 57] , two of the studies used laparoscopy (with or without clinical diagnoses) and defined their outcome as salpingitis [59, 61] , and the remaining six studies clinically defined their outcome as PID [20, 31, 47, 58, 60, 62] . Five of the studies used a case-control study design [31, 47, 57, 58, 60] , four of the studies used a cross-sectional design [20, 38, 59, 61] , and one of the studies used a cohort design [62] .
In the meta-analysis of all ten included studies, there was a statistically significant association between M. genitalium and PID with a pooled OR of 2.14 (95% CI: 1.31, 3.49) (Fig   8) . There was only moderate evidence of between-study heterogeneity (I 2 =51.3% (95% CI: 0.0%, 76.3%) and no significant publication bias (Begg p-value=0.98, Egger p-value=0.055).
DISCUSSION
This meta-analysis of the published literature on the association of M. genitalium and female reproductive tract disease was remarkably consistent, and demonstrated an approximately two-fold increase in risk across all syndromes, with pooled estimates ranging from 1.7 to 2.4.
These pooled estimates were all statistically significant, with the exception of analyses of infertility. In contrast, the number of studies evaluating the association between M. genitalium and stillbirth (n=2), as well as those evaluating the association between M. genitalium and ectopic pregnancy (n=1) was too small to draw definitive conclusions. In all analyses, the pooled estimates generated from the crude effect estimates were not substantially different than those derived from the adjusted effect estimates (when available), highlighting the robustness of these results.
One previous meta-analysis of the association between M. genitalium and cervicitis [1] , and one systematic review [2] were published in 2011. Our analysis included an additional eight studies of cervicitis [19-21, 23, 27, 30-32] , five of PID [20, 31, 59, 61, 62] , two of infertility [38, 39] , and three of pregnancy outcomes [14, 46, 50] . The addition of these new studies allowed quantitative synthesis of the literature and extended earlier qualitative assessments suggesting that M. genitalium was related to each of these four female reproductive tract disease syndromes by confirming statistically significant associations in most cases.
The pooled estimate for the association between M. genitalium and cervicitis that we observed here (summary estimate=1.7) was similar to that observed in the earlier systematic review [2] and the previous meta-analysis, which also employed a random effects model (pooled estimate 2.2 (95% CI: 1.6-2.9)) [1] . This was despite the exclusion of three of the studies in the original meta-analysis that did not meet our inclusion criteria (one study was not in English [63] , one study did not report on cervicitis but was included in the PID analysis [58] , and one study evaluated the association between cervical HIV-1 DNA shedding and M. genitalium infection, not cervicitis [64] ) and the inclusion of an additional eight studies published since then [19-21, [66] ; infectious agents typically contribute to only a small proportion of preterm births. Therefore, it was remarkable that we observed a two-fold increase in risk for preterm birth and spontaneous abortion. This finding was consistent with the earlier systematic review [2] , and included an additional three studies of pregnancy outcomes [14, 46, 50] . Our decision to consider preterm delivery (<37 weeks gestation) and spontaneous abortion (<16 weeks gestation) together as conditions due to a similar mechanism (premature expulsion of the fetus) was supported by the consistency of the effect estimates in stratified and combined analyses. Nevertheless, while this suggests that M. genitalium may cause adverse pregnancy outcome, the prevalence of this organism in low risk populations is generally low (2.0%) [2, 3] .
Therefore, in considering whether pregnant women should be screened for M. genitalium, limiting this to high risk pregnant women may be preferable.
Risk for PID was twice as high among women with M. genitalium in this meta-analysis, consistent with earlier qualitative assessments [2] , and this analysis incorporated an additional five studies published since the last review [20, 31, 59, 61, 62] . Notably, two excluded studies that recently reported the greatest risk for PID were conference abstracts that did not meet the inclusion criteria for our meta-analysis [67, 68] genitalium (e.g., azithromycin or moxifloxacin) may be effective in some persistent cases of PID.
In the United States approximately 11% of women age 15-44 have impaired fecundity [70] and M. genitalium was associated with an over three-fold increased risk of infertility in this study. This increased risk was similar to the qualitative observations from the prior systematic review [2] , and accounted for two additional studies of infertility [38, 39] . Notably, one study included in our meta-analysis compared women with infertility from all causes (tubal obstruction, unexplained infertility, male infertility, and ovulation disorders) to women with proven fertility [40] . The information reported in the paper did not allow us to exclude failure to conceive due to male infertility and this may have reduced the pooled effect estimate for infertility. Given the small number of studies on M. genitalium and infertility as well as the instability of the summary estimate in the main and sub-analyses, more studies on this topic are warranted.
While a multitude of studies evaluating the association between M. genitalium and nongonococcal urethritis in men exist, and a substantial number assessing the relationship with cervicitis in women, relatively little has been done to define the association between M.
genitalium and stillbirth or ectopic pregnancy. Considering the prevalence of stillbirth can range from 0.5% in developed countries to more than 3% in less developed countries, this is an important area of future research [71] . Additionally, since only one study has evaluated the association between M. genitalium and ectopic pregnancy, no clear conclusions could be drawn.
Further research on both of these topics would be beneficial.
All studies included in these meta-analyses were assessed for quality based on defined criteria (Appendix B and C) and all met criteria for good or fair. Since none of the included studies were considered poor, no sensitivity analyses excluding poor quality studies were done.
Quality ratings were tied to the use of the study data for the analysis of a given syndrome and do not necessarily reflect the intrinsic quality of the study itself. Because of this, in some cases the same study received different quality ratings when it was included in more than one analysis if the quality of the information provided differed for individual outcomes.
A major strength of these meta-analyses was our ability to calculate a pooled estimate for each outcome, summarizing studies with varying exposure and outcome measurements and genitalium's association with female reproductive health outcomes than other STIs, and the were number of studies was not sufficient to explore stratified analyses for all of the pregnancy outcomes, PID, and female infertility. However, it was possible to evaluate subgroups for cervicitis, and none of the subgroups were substantially different than the full pooled estimate, lending confidence to our results. Despite a variety of exposure measures (NAATs vs. serology), and outcome definitions, heterogeneity as measured by the I 2 -statistic was moderate to low in all of the analyses presented. The heterogeneity that was present reflected heterogeneity in point estimates rather than study characteristics; however, analyzing these studies as a whole instead of by subgroup characteristics was a necessity due to small numbers of studies for most outcomes.
calculated from available data. Our observations that the associations were robust across crude and adjusted effect estimates lends further confidence to these results. A possible limitation to all meta-analyses is the influence of publication bias on the overall pooled estimates. Although publication bias based on statistical tests was not significant for any of the outcomes evaluated, since M. genitalium is an emerging STI, authors may be hesitant to publish articles showing a lack of a significant association, and our pooled estimates may overestimate the true effect to some degree.
Our meta-analyses suggest a significant association between M. genitalium and cervicitis, pregnancy outcomes (preterm birth and spontaneous abortion) and PID. Additionally, our analysis strongly suggests a possible association between M. genitalium and female infertility.
These associations with adverse reproductive health outcomes suggest that screening high-risk women for M. genitalium may be warranted. 
